Chewing Gum on Postoperative Ileus in Children
Launched by UNIVERSITY OF MANITOBA · Sep 7, 2018
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at whether chewing gum can help children recover faster after abdominal surgery. When kids have surgery, it can take some time for their stomachs and intestines to start working normally again, which is called bowel recovery. The study wants to see if letting children chew gum after surgery can speed up this process, allowing them to eat solid food sooner and leave the hospital quicker.
To participate in this study, children need to be at least 4 years old and have had abdominal surgery that requires them to stay in the hospital for more than a day. Unfortunately, younger children or those who can't chew gum for any reason, like certain medical conditions, won't be able to join. If eligible, participants will be asked to chew gum as part of their recovery process, and researchers will monitor how it affects their progress. This trial is currently recruiting participants, and families can get more information on how to join.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children more than or equal to 4 years of age
- • Children who undergo abdominal surgery (both laparoscopic or open)
- • Children who have an expected postoperative length of stay more than 24 hours
- Exclusion Criteria:
- • Children who are less than 4 years of age
- • Children who are unable to chew gum/swallow (e.g. intubated, decreased level of consciousness, cognitive or physical disability)
- • Children or their parents are not willing to sign consent
- • Children or their parents are unable to follow directions regarding gum chewing,
- • Children who have a GI dysmotility disorder (e.g. chronic intestinal pseudo-obstruction)
About University Of Manitoba
The University of Manitoba, a leading research institution in Canada, is dedicated to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive expertise in medical research, public health, and community engagement to conduct rigorous and ethical clinical studies. The institution aims to translate scientific findings into practical applications that enhance patient care and improve health outcomes. Committed to fostering a culture of excellence and integrity, the University of Manitoba prioritizes participant safety and scientific validity in all its clinical research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Winnipeg, Manitoba, Canada
Patients applied
Trial Officials
Anna Shawyer, MD, MSc
Principal Investigator
University of Manitoba
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials